ATLANTA--(BUSINESS WIRE)--
Holzer & Holzer, LLC is investigating whether certain statements issued by Psychemedics Corporation (“Psychemedics” or the “Company”) (NASDAQ: PMD) complied with federal securities laws. On January 31, 2017, it was reported that Psychemedics Brasil Exames Toxicologicos Ltda. and Laboratorios Omega Brasil Ltda. were ordered to compensate Omega Laboratories, Inc. USA for losses caused by anticompetitive practices used for the purpose of “preventing other companies from accessing (the) market.” The ruling notes that Psychemedics Brazil and O. Brazil used “cartel practices,” in an attempt to form a drug testing monopoly which included unenforceable and exclusive contracts with collection sites, “all with a view to limit the entry and operation of new companies in the market.” Psychemedics stock price plummeted following this news.
If you purchased Psychemedics stock between July 26, 2016 and January 31, 2017, you are encouraged to contact Corey D. Holzer, Esq. at [email protected] or Marshall P. Dees, Esq. at [email protected], or by toll-free telephone at (888) 508-6832 to discuss your legal rights.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170131006147/en/
